Memorial Sloan-Kettering Cancer Center
Dr. David Abramson is the first chief of the ophthalmic oncology service at Memorial Sloan-Kettering Cancer Center in New York. His clinical interests include retinoblastoma, ocular melanomas, orbital tumors and other areas of ophthalmic oncology. He has published more than 400 books, chapters, original articles, scientific reviews, audiotapes, and videotapes, and served as the editor of the American Academy of Ophthalmology's instruction book on ophthalmic oncology. He has delivered more than 400 lectures worldwide, including in France, Italy, Switzerland, Israel, China, Hong Kong, Canada, Mexico, Venezuela, Peru, Brazil, and Argentina.
Described as the "Dean of Retinoblastoma," Dr. Abramson is a leader at the longest continually operating retinoblastoma center in the world, with the longest follow-up of the largest number of patients ever. He has introduced many new treatments for retinoblastoma that have been adopted by other centers worldwide. These include the novel use of chemotherapy delivered around the eye to prevent systemic toxicity of intravenous medication. His team's studies on the long-term complications of cancer diathesis in this disease have been published extensively in JAMA, as well as ophthalmic and oncology journals.
He has received awards from the Swiss Ophthalmological Society (for work in childhood eye cancer and genetics), the Association for Research in Vision (for contributions to clinical ophthalmological research), the Helen Keller Society (for work with blind and limited-sighted children), and the New York State Ophthalmological Society (for his humanitarian approach to patients). I have received many teaching awards, and he has received the Honor Award and the Senior Honor Award from the American Academy of Ophthalmology.
Dr. Abramson earned his medical degree from the Albert Einstein College of Medicine in New York. After completing his residency in ophthalmology and a full year of research involving ultrasound and cancer of the eye, he completed his fellowship in ophthalmic oncology at Columbia-Presbyterian Medical Center and also spent additional time training at the Armed Forces Institute of Pathology in Washington, DC.
You need to be logged in to save this episode to a playlist.